Article

Stone recurrence: Advice for young urologists

In this video, Juan Calle, MD, of Cleveland Clinic, explains what he would tell a young urologist who wants to become an expert in stone prevention and minimizing recurrence.

Juan Calle, MD, of Cleveland Clinic, explains what he would tell a young urologist who wants to become an expert in stone prevention and minimizing recurrence.

Related Videos
Urinary bladder | Image Credit: © magicmine - stock.adobe.com
Blurred interior of hospital | Image Credit: © jakkapan - stock.adobe.com
Human urinary bladder | Image Credit: © magicmine - stock.adobe.com
3d rendered illustration - bladder cancer | Image Credit: © Sebastian Kaulitzki - stock.adobe.com
Raevti Bole, MD, answers a question during a video interview
Illustration of Benign Prostatic Hyperplasia | Image Credit: © Judith - stock.adobe.com
Petar Bajic, MD, answers a question during a video interview
Raevti Bole, MD, answers a question during a video interview
Human kidney stones | Image Credit: © freshidea - stock.adobe.com
Related Content
Top 10 kidney stone stories in 2024
December 25th 2024

Top 10 kidney stone stories in 2024

Hannah Clarke
As the year comes to a close, we revisit some of this year’s top content on kidney stone management.
Dr. Schwen on focal therapies for prostate cancer
January 11th 2024

Dr. Schwen on focal therapies for prostate cancer

Cleveland Clinic
Zeyad Schwen, MD, a urologic oncologist at Cleveland Clinic, discusses how patient factors and cancer characteristics are key to deciding between focal therapies and whole gland treatment for prostate cancer.
FDA greenlights phase 1/2 trial of gene editing therapy for primary hyperoxaluria 1
December 19th 2024

FDA greenlights phase 1/2 trial of gene editing therapy for primary hyperoxaluria 1

Hannah Clarke
The redePHine trial is expected to launch in the first half of 2025.
Why kidney stones will become more prevalent over time
February 17th 2022

Why kidney stones will become more prevalent over time

Urology Times staff
“The prevalence of kidney stones has increased over 80% over the last 30 years, and the epidemiology has changed such that it's beginning at a younger age now,” says Gregory Tasian, MD, MSc, MSCE.
Survey reveals generational trends in men’s health habits
September 5th 2024

Survey reveals generational trends in men’s health habits

Hannah Clarke
“We saw in the survey that men are concerned with how the health decisions they make now will affect them in the future,” says Petar Bajic, MD.
FDA grants rare pediatric disease designation to YOLT-203 for primary hyperoxaluria type 1
September 4th 2024

FDA grants rare pediatric disease designation to YOLT-203 for primary hyperoxaluria type 1

Hannah Clarke
YOLT-203 is currently being assessed in the early phase 1 YOLT-203-101 trial.
© 2025 MJH Life Sciences

All rights reserved.